BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 32516978)

  • 1. Insights into the Role of Estrogen Receptor β in Triple-Negative Breast Cancer.
    Sellitto A; D'Agostino Y; Alexandrova E; Lamberti J; Pecoraro G; Memoli D; Rocco D; Coviello E; Giurato G; Nassa G; Tarallo R; Weisz A; Rizzo F
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32516978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells.
    Shanle EK; Zhao Z; Hawse J; Wisinski K; Keles S; Yuan M; Xu W
    Mol Endocrinol; 2013 Oct; 27(10):1762-75. PubMed ID: 23979844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic roles of estrogen receptor-β and insulin-like growth factor-2 in triple-negative breast cancer.
    Hamilton N; Márquez-Garbán D; Mah V; Fernando G; Elshimali Y; Garbán H; Elashoff D; Vadgama J; Goodglick L; Pietras R
    Biomed Res Int; 2015; 2015():925703. PubMed ID: 25874233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor-beta is a potential target for triple negative breast cancer treatment.
    Austin D; Hamilton N; Elshimali Y; Pietras R; Wu Y; Vadgama J
    Oncotarget; 2018 Sep; 9(74):33912-33930. PubMed ID: 30338035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERβ inhibits cyclin dependent kinases 1 and 7 in triple negative breast cancer.
    Reese JM; Bruinsma ES; Monroe DG; Negron V; Suman VJ; Ingle JN; Goetz MP; Hawse JR
    Oncotarget; 2017 Nov; 8(57):96506-96521. PubMed ID: 29228549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor beta impacts hormone-induced alternative mRNA splicing in breast cancer cells.
    Dago DN; Scafoglio C; Rinaldi A; Memoli D; Giurato G; Nassa G; Ravo M; Rizzo F; Tarallo R; Weisz A
    BMC Genomics; 2015 May; 16(1):367. PubMed ID: 25956916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells.
    Chang EC; Frasor J; Komm B; Katzenellenbogen BS
    Endocrinology; 2006 Oct; 147(10):4831-42. PubMed ID: 16809442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated estrogen receptor β expression in triple negative breast cancer cells is associated with sensitivity to doxorubicin by inhibiting the PI3K/AKT/mTOR signaling pathway.
    Lei S; Fan P; Wang M; Zhang C; Jiang Y; Huang S; Fang M; He Z; Wu A
    Exp Ther Med; 2020 Aug; 20(2):1630-1636. PubMed ID: 32742395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer.
    Aspros KGM; Carter JM; Hoskin TL; Suman VJ; Subramaniam M; Emch MJ; Ye Z; Sun Z; Sinnwell JP; Thompson KJ; Tang X; Rodman EPB; Wang X; Nelson AW; Chernukhin I; Hamdan FH; Bruinsma ES; Carroll JS; Fernandez-Zapico ME; Johnsen SA; Kalari KR; Huang H; Leon-Ferre RA; Couch FJ; Ingle JN; Goetz MP; Hawse JR
    NPJ Breast Cancer; 2022 Feb; 8(1):20. PubMed ID: 35177654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
    Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
    J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro.
    Schüler-Toprak S; Häring J; Inwald EC; Moehle C; Ortmann O; Treeck O
    BMC Cancer; 2016 Dec; 16(1):951. PubMed ID: 28003019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of Mitochondrial ERβ Expression Inhibits Triple-Negative Breast Cancer Tumor Progression by Activating Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Kim JE; Han J; Kim TH; Jang SW
    Cell Physiol Biochem; 2019; 52(3):468-485. PubMed ID: 30873822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells.
    Secreto FJ; Monroe DG; Dutta S; Ingle JN; Spelsberg TC
    J Cell Biochem; 2007 Aug; 101(5):1125-47. PubMed ID: 17520659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen signaling: a subtle balance between ER alpha and ER beta.
    Matthews J; Gustafsson JA
    Mol Interv; 2003 Aug; 3(5):281-92. PubMed ID: 14993442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic target.
    Skliris GP; Leygue E; Watson PH; Murphy LC
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):1-10. PubMed ID: 18243688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
    Gougelet A; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer.
    Paris O; Ferraro L; Grober OM; Ravo M; De Filippo MR; Giurato G; Nassa G; Tarallo R; Cantarella C; Rizzo F; Di Benedetto A; Mottolese M; Benes V; Ambrosino C; Nola E; Weisz A
    Oncogene; 2012 Sep; 31(38):4196-206. PubMed ID: 22231442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
    Lu W; Katzenellenbogen BS
    Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of estrogen receptor beta in ovarian carcinogenesis.
    Bardin A; Hoffmann P; Boulle N; Katsaros D; Vignon F; Pujol P; Lazennec G
    Cancer Res; 2004 Aug; 64(16):5861-9. PubMed ID: 15313930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.